相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone
Preety Panwar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice
Pablo Villa-Perez et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Novel Noncatalytic Substrate-Selective p38α-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity
Nirav G. Shah et al.
JOURNAL OF IMMUNOLOGY (2017)
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus
Wei-Jen Tang
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Fluorescence polarization assays in high-throughput screening and drug discovery: a review
Matthew D. Hall et al.
METHODS AND APPLICATIONS IN FLUORESCENCE (2016)
Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
Franck Madoux et al.
SCIENTIFIC REPORTS (2016)
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O. Abdul-Hay et al.
ACS CHEMICAL BIOLOGY (2015)
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances
John J. V. McMurray
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme
Julie Charton et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo
Timothy B. Durham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes
Anna M. Knapinska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Systematic discovery of linear binding motifs targeting an ancient protein interaction surface on MAP kinases
Andras Zeke et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Rebecca Deprez-Poulain et al.
NATURE COMMUNICATIONS (2015)
SHELXT - Integrated space-group and crystal-structure determination
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2015)
Crystal structure refinement with SHELXL
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2015)
Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination
Lennard Krause et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2015)
Insulin-Degrading Enzyme Inhibition, a Novel Therapy for Type 2 Diabetes?
Safia Costes et al.
CELL METABOLISM (2014)
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis
Julie Charton et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Juan Pablo Maianti et al.
NATURE (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1
T. Justin Rettenmaier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Type 2 Diabetes-Associated Gene Ide Is Required for Insulin Secretion and Suppression of α-Synuclein Levels in β-Cells
Par Steneberg et al.
DIABETES (2013)
Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity
Samer O. Abdul-Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme
Lauren A. McCord et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
Bo Ahren
VASCULAR HEALTH AND RISK MANAGEMENT (2013)
Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site
Katrien Busschots et al.
CHEMISTRY & BIOLOGY (2012)
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
Roger H. Unger et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Methyl Effects on Protein-Ligand Binding
Cheryl S. Leung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and Profiling of a Diverse Collection of Azetidine-Based Scaffolds for the Development of CNS-Focused Lead-like Libraries
Jason T. Lowe et al.
JOURNAL OF ORGANIC CHEMISTRY (2012)
Data processing and analysis with the autoPROC toolbox
Clemens Vonrhein et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
Kelsey C. Duggan et al.
NATURE CHEMICAL BIOLOGY (2011)
Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
Samer O. Abdul-Hay et al.
PLOS ONE (2011)
Guidelines for accurate EC50/IC50 estimation
J. L. Sebaugh
PHARMACEUTICAL STATISTICS (2011)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro
Bart S. Hendriks et al.
BMC SYSTEMS BIOLOGY (2010)
Emerging principles in protease-based drug discovery
Marcin Drag et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties
Eun Suk Song et al.
PLOS ONE (2010)
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
Malcolm A. Leissring et al.
PLOS ONE (2010)
OLEX2: a complete structure solution, refinement and analysis program
Oleg V. Dolomanov et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme
Enrico Malito et al.
BIOCHEMISTRY (2008)
Amyloid β-degrading cryptidases:: insulin degrading enzyme, presequence peptidase, and neprilysin
E. Malito et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE
Hookang Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of MMP-2 gelatinolysis by targeting exodomain-substrate interactions
Xiaoping Xu et al.
BIOCHEMICAL JOURNAL (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
USER fusion: a rapid and efficient method for simultaneous fusion and cloning of multiple PCR products
Fernando Geu-Flores et al.
NUCLEIC ACIDS RESEARCH (2007)
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
Yuequan Shen et al.
NATURE (2006)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Substrate activation of insulin-degrading enzyme (insulysin) - A potential target for drug development
ES Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Degradation of amylin by insulin-degrading enzyme
RG Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
